Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What happens to the 500+ million NOLS in a chapter 11 for PIOI?
I bought more SINO today too on this pullback.
Thanks ash very informative post. I read something about how they lost contracts before Langley stepped in that they attributed to cost cutting measures because of the poor economy.
Hi ash I was reading more about PIOI that was formerly ACPW. So Langley/Piller buys all their assets and sells their ACPW products but the new PIOI which had to change name from APCW to PIOI has around 20 patents and NOLS to form a new company. So are these about 20 other patents for new products that are being developed that are different from the former ACPW products that Langley/Piller are selling? In case you did not know ACPW still has a working website. I am just trying to understand more clearly what PIOI is trying to accomplish in forming a new company.
Yes kei I saw it hit 9.79 today. I am also up big on SINO so a great day for me!
Great info on SINO and COSCO and yes you are right that this collaboration will be great future news for us SINO shareholders. Looking forward to tomorrow!
Great find ash! Thanks
Hi ash Just seen on Stocktwits from March 2 the post referencing someone thinking RLGT could buy SINO at link below.
https://stocktwits.com/message/76060724
Agree and thanks ash. I feel very lucky to have my SINO shares at $2.53. This company will be exploding in the near future with all these great numbers and recent developments.
This will be an easy double at the very least.
OK thanks and they will be fine going alone anyway.
Thanks ash and hard to believe this stock is sitting at around 2.50. Patience again will be rewarded here.
Good luck to us on OCUL. I am still holding in 2 different accounts I am going to check out AUPH also.
$SINO ASH and KEI just saw on Yahoo message board on SINO about possibility of SINO being bought out by RGLT by June at link below. What do you both think about this? So glad I got in this one today after news release after hours yesterday. Hoping to recover my gains from selling XTNT too early at 70 cents.
http://finance.yahoo.com/quote/SINO/community?p=SINO
WOW 8348 watchers on SINO on Stocktwits
WOW 8348 watchers on SINO on Stocktwits.
$SINO In SINO today at $2.53
$SINO In SINO today at $2.53
Thanks kei I am up 27% on that trade and of course wish I would have waited but will be watching for a pullback.
$XTNT .83 +36% XTNT hit as high as .95 with high volume of 7,782,845. I sold early at .70 for a good gain in hopes for another re entry after earnings on a pull back. Last time it went to around .70 to .75 it pulled back and was surprised today so not sure if I will be able to enter again even under .70 but I am keeping this on my watch list for sure.
XTNT .61 +19.63 XTNT is reporting 4th quarter and total year earnings after hours on Thursday 3/9/17. XTNT was up 19.63% on 1,570,678 volume. They were also up 3 cents in after hours to .64
$XTNT .61 +19.63 XTNT is reporting 4th quarter and total year earnings after hours on Thursday 3/9/17. XTNT was up 19.63% on 1,570,678 volume. They were also up 3 cents in after hours to .64
$XTNT.61 +19.63% XTNT is reporting 4th quarter and total year earnings after hours on Thursday 3/9/17. XTNT was up 19.63% on 1,570,678 volume. They were also up 3 cents in after hours to .64
Noticed also ash and can not wait till news!
$OCUL $8.57 Bret Jensen from Seeking Alpha also owns this stock.
Not sure kei but I forgot to add on here and passed the edit limit that Bret Jensen from Seeking Alpha also owns this stock. I am thinking that with just a manufacturing issue to contend that should be an easy fix that this should at least hit $16 on approval of Dextensa on July 19 2017 the PDUFA date which is a 100% return for me at $8 entry point. Yes you are right that it hit $35-$40 range prior to CRL so even with 14% dillution the higher price targets of $35-$38 seem very possible when you factor in their other products also.
OCUL $8.57 Sorry about this but I forgot to include the link on the shelf offering they did for 3,571,429 shares at $7 that was supposed to close by January 27, 2017. They had 25,188,571 shares before the offering so they now have 28,760,000 shares outstanding which was about a 14% increase in shares. I have added this link at the top below to keep all of the links on one message post. Bret Jensen from Seeking Alpha also owns this stock.
http://finance.yahoo.com/news/ocular-therapeutix-inc-announces-pricing-130000530.html
http://www.ocutx.com
http://seekingalpha.com/article/4045270-ocular-therapeutix-recent-rally-just-beginning
http://seekingalpha.com/article/4045873-ocular-therapeutix-ocul-presents-19th-annual-bio-ceo-and-investor-conference
http://finance.yahoo.com/m/1ede7fda-0b07-302a-8079-da7813c8137c/biotech-movers-and-shakers%3A.html
http://finance.yahoo.com/news/blog-coverage-ocular-therapeutix-announced-131500482.html
http://finance.yahoo.com/news/ocular-therapeutix-announces-fda-acceptance-130000286.html
http://finance.yahoo.com/m/700949a3-a154-30f9-aae5-00379543dd1f/why-ocular-therapeutix-inc.html
https://www.thestreet.com/story/13891120/1/ocular-therapeutix-announces-successful-topline-results-for-both-inflammation-and-pain-primary-efficacy-endpoints-from-phase-3-clinical-trial-of-dextenza.html
$OCUL $8.57 Sorry about this but I forgot to include the link on the shelf offering they did for 3,571,429 shares at $7 that was supposed to close by January 27, 2017. They had 25,188,571 shares before the offering so they now have 28,760,000 shares outstanding which was about a 14% increase in shares. I have added this link at the top below to keep all of the links on one message post. Bret Jensen from Seeking Alpha also owns this stock.
http://finance.yahoo.com/news/ocular-therapeutix-inc-announces-pricing-130000530.html
http://www.ocutx.com
http://seekingalpha.com/article/4045270-ocular-therapeutix-recent-rally-just-beginning
http://seekingalpha.com/article/4045873-ocular-therapeutix-ocul-presents-19th-annual-bio-ceo-and-investor-conference
http://finance.yahoo.com/m/1ede7fda-0b07-302a-8079-da7813c8137c/biotech-movers-and-shakers%3A.html
http://finance.yahoo.com/news/blog-coverage-ocular-therapeutix-announced-131500482.html
http://finance.yahoo.com/news/ocular-therapeutix-announces-fda-acceptance-130000286.html
http://finance.yahoo.com/m/700949a3-a154-30f9-aae5-00379543dd1f/why-ocular-therapeutix-inc.html
https://www.thestreet.com/story/13891120/1/ocular-therapeutix-announces-successful-topline-results-for-both-inflammation-and-pain-primary-efficacy-endpoints-from-phase-3-clinical-trial-of-dextenza.html
$OCUL $8.57 Sorry about this but I forgot to include the link on the shelf offering they did for 3,571,429 shares at $7 that was supposed to close by January 27, 2017. They had 25,188,571 shares before the offering so they now have 28,760,000 shares outstanding which was about a 14% increase in shares. I have added this link at the top below to keep all of the links on one message post.
http://finance.yahoo.com/news/ocular-therapeutix-inc-announces-pricing-130000530.html
http://www.ocutx.com
http://seekingalpha.com/article/4045270-ocular-therapeutix-recent-rally-just-beginning
http://seekingalpha.com/article/4045873-ocular-therapeutix-ocul-presents-19th-annual-bio-ceo-and-investor-conference
http://finance.yahoo.com/m/1ede7fda-0b07-302a-8079-da7813c8137c/biotech-movers-and-shakers%3A.html
http://finance.yahoo.com/news/blog-coverage-ocular-therapeutix-announced-131500482.html
http://finance.yahoo.com/news/ocular-therapeutix-announces-fda-acceptance-130000286.html
http://finance.yahoo.com/m/700949a3-a154-30f9-aae5-00379543dd1f/why-ocular-therapeutix-inc.html
https://www.thestreet.com/story/13891120/1/ocular-therapeutix-announces-successful-topline-results-for-both-inflammation-and-pain-primary-efficacy-endpoints-from-phase-3-clinical-trial-of-dextenza.html
Hi ash
I saw that too and thanks for posting. I am so excited about upcoming news on PIOI and this one could really be huge for sure. Keep an eye on OCUL. I got in this one awhile back at $8 and it ran to almost $11 recently and pulled back to almost $8 from getting a level 2 review on Dextensa instead of a level 1 but their PDUFA is July 19 and they also have other products. You could possibly get a better entry point however.
OCUL $8.96 Check out OCUL Occular Therapeutics with a July 19 2017 PDUFA for Dextensa an eye medication and they have other products also. DD links are posted below. This PDUFA is for a resubmission for Dextensa from a previous CRL for manufacturing issues that should have been corrected by now. I saw an article recently that they have a median price target of $18 and one analyst has a $38 price target.
http://www.ocutx.com
http://seekingalpha.com/article/4045270-ocular-therapeutix-recent-rally-just-beginning
http://seekingalpha.com/article/4045873-ocular-therapeutix-ocul-presents-19th-annual-bio-ceo-and-investor-conference
http://finance.yahoo.com/m/1ede7fda-0b07-302a-8079-da7813c8137c/biotech-movers-and-shakers%3A.html
http://finance.yahoo.com/news/blog-coverage-ocular-therapeutix-announced-131500482.html
http://finance.yahoo.com/news/ocular-therapeutix-announces-fda-acceptance-130000286.html
http://finance.yahoo.com/m/700949a3-a154-30f9-aae5-00379543dd1f/why-ocular-therapeutix-inc.html
https://www.thestreet.com/story/13891120/1/ocular-therapeutix-announces-successful-topline-results-for-both-inflammation-and-pain-primary-efficacy-endpoints-from-phase-3-clinical-trial-of-dextenza.html
OCUL $8.96 Check out OCUL Occular Therapeutics with a July 19 2017 PDUFA for Dextensa an eye medication and they have other products also. DD links are posted below. This PDUFA is for a resubmission for Dextensa from a previous CRL for manufacturing issues that should have been corrected by now. I saw an article recently that they have a median price target of $18 and one analyst has a $38 price target.
http://www.ocutx.com
http://seekingalpha.com/article/4045270-ocular-therapeutix-recent-rally-just-beginning
http://seekingalpha.com/article/4045873-ocular-therapeutix-ocul-presents-19th-annual-bio-ceo-and-investor-conference
http://finance.yahoo.com/m/1ede7fda-0b07-302a-8079-da7813c8137c/biotech-movers-and-shakers%3A.html
http://finance.yahoo.com/news/blog-coverage-ocular-therapeutix-announced-131500482.html
http://finance.yahoo.com/news/ocular-therapeutix-announces-fda-acceptance-130000286.html
http://finance.yahoo.com/m/700949a3-a154-30f9-aae5-00379543dd1f/why-ocular-therapeutix-inc.html
https://www.thestreet.com/story/13891120/1/ocular-therapeutix-announces-successful-topline-results-for-both-inflammation-and-pain-primary-efficacy-endpoints-from-phase-3-clinical-trial-of-dextenza.html
$OCUL $8.96 Check out OCUL Occular Therapeutics with a July 19 2017 PDUFA for Dextensa an eye medication and they have other products also. DD links are posted below. This PDUFA is for a resubmission for Dextensa from a previous CRL for manufacturing issues that should have been corrected by now. I saw an article recently that they have a median price target of $18 and one analyst has a $38 price target.
http://www.ocutx.com
http://seekingalpha.com/article/4045270-ocular-therapeutix-recent-rally-just-beginning
http://seekingalpha.com/article/4045873-ocular-therapeutix-ocul-presents-19th-annual-bio-ceo-and-investor-conference
http://finance.yahoo.com/m/1ede7fda-0b07-302a-8079-da7813c8137c/biotech-movers-and-shakers%3A.html
http://finance.yahoo.com/news/blog-coverage-ocular-therapeutix-announced-131500482.html
http://finance.yahoo.com/news/ocular-therapeutix-announces-fda-acceptance-130000286.html
http://finance.yahoo.com/m/700949a3-a154-30f9-aae5-00379543dd1f/why-ocular-therapeutix-inc.html
https://www.thestreet.com/story/13891120/1/ocular-therapeutix-announces-successful-topline-results-for-both-inflammation-and-pain-primary-efficacy-endpoints-from-phase-3-clinical-trial-of-dextenza.html
205 K shares of PIOI for me. Bought about 25000 more today.
I still have a lot of warrants. Have to wait and see at this point. Huge upside still if all goes well. As a positive note I am thinking that possibly there is a greater chance that they may decide to just sell the entire company including the new acquisition with all this negative publicity which would be even better for us shareholders.
kei and ash Just curious if you are still in KTOVW. I am planning to hold KTOVW and see what happens since I am down big at 91 cents average.
Not sure on approval but they would have an adcom meeting with FDA and also schedule PDUFA date. If you do a search on internet you could come up with average time frame for this to happen.
ZSAN Bought ZSAN at 1.01 and sold at 2.25 in premarket today for a 122% gain. Good call on this one ash!!!
BPMX In BPMX at .44 today. Wish I could have gotten lower but sometimes you have to just take what the market gives you. Still feel good about a .44 entry point.